alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 1500.41 Nominations and appointments. ( a ) For the initial Board, nominations shall be made and submitted to the Secretary by manufacturers. The Secretary shall consider the nominations submitted and other manufacturers for appointment, as the Secretary may deem appropriate. The Secretary shall appoint the members and alternate members of the initial Board.
( b ) From the nominations, the Secretary shall appoint the 15-25 members of the Board and 6 alternate members of the Board within a reasonable time after receiving nominations. If a voting member vacates the appointment, the Secretary will appoint one of the alternate members to fill the unexpired term. The Secretary will provide the Board an opportunity to offer a nominee as successor to fill the term of the alternate member. In any case in which the Board fails to submit nominations for any open position, the Secretary shall appoint a member qualifying for the position under the criteria set forth in § 1500.40.
( c ) As terms expire or vacancies occur among members and alternate members, nominations and those interested in being considered for Board membership, including self-nominations, may submit such nominations to the Board. For each expired or vacant position, the Board will evaluate the nominations received, verify the willingness of nominees to serve, and then will submit to the Secretary at least three nominees for each such position. The Secretary may also receive nominations and may forward them to the Board for their consideration. The Secretary is not bound by the recommendations of the Board; in selecting members, the Secretary will consider the recommendations of the Board, individual expertise, distribution of appointments, and more expansive input from sources available to the Secretary. For the initial Board, from the list of nominees not selected for appointment, the Secretary will choose and appoint six alternate members for the Board. Alternate members will be non-voting members of the Board.
# L_2023049EN.01002601.xml

| 16.2.2023 | EN | Official Journal of the European Union | L 49/26 |
| --- | --- | --- | --- |

16.2.2023

EN

Official Journal of the European Union

L 49/26

---

DECISION OF THE EEA JOINT COMMITTEE No 10/2020

of 7 February 2020

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2023/288]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Regulation (EU) 2019/1390 of 31 July 2019 amending, for the purpose of its adaptation to technical progress, the Annex to Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Regulation (EU) 2019/1390 of 31 July 2019 amending, for the purpose of its adaptation to technical progress, the Annex to Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (1) is to be incorporated into the EEA Agreement.

| (2) | Annex II to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 12zza (Commission Regulation (EC) No 440/2008) of Chapter XV of Annex II to the EEA Agreement:

| ‘— | 32019 R 1390: Commission Regulation (EU) 2019/1390 of 31 July 2019 (OJ L 247, 26.9.2019, p. 1).’ |
| --- | --- |

‘—

32019 R 1390: Commission Regulation (EU) 2019/1390 of 31 July 2019 (OJ L 247, 26.9.2019, p. 1).’

Article 2

The text of Regulation (EU) 2019/1390 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 8 February 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 7 February 2020.

For the EEA Joint Committee

The President

Clara GANSLANDT

---

(1)  
  OJ L 247, 26.9.2019, p. 1.

1

(*1)  No constitutional requirements indicated.

*1

---
IIB 

108TH CONGRESS 

2D SESSION H. R. 2121

IN THE SENATE OF THE UNITED STATES 

JULY 7, 2004

Received; read twice and referred to the Committee on Foreign Relations 

AN ACT

To amend the Eisenhower Exchange Fellowship Act of 1990 

to authorize additional appropriations for the Eisenhower 

Exchange Fellowship Program Trust Fund, and for other 

purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,
2

HR 2121 RFS 

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Eisenhower Exchange 

3 Fellowship Program Trust Fund Enhancement Act of 

4 2004’’. 

5 SEC. 2. FINDINGS. 

6 Congress finds the following: 

7 (1) 2003 marks the 50th anniversary of the es8 tablishment of the Eisenhower Exchange Fellowship 

9 program. 

10 (2) The Eisenhower Exchange Fellowship pro11 gram was founded to honor the 34th President, 

12 Dwight D. Eisenhower, for his character, courage, 

13 patriotism, and commitment to international under14 standing through exchange. 

15 (3) Over the past 50 years the Eisenhower Ex16 change Fellowship program has exposed thousands 

17 of leaders throughout the world to the values of 

18 American political institutions, private sector com19 merce, educational opportunities, and cultural and 

20 societal traditions. 

21 (4) Eisenhower Exchange Fellows worldwide 

22 have assumed positions of leadership in their respec23 tive countries, whether in the fields of government, 

24 industry, or civil society, and they retain links to the 

25 United States through their membership in Eisen26 hower Exchange Fellowships. 
3

HR 2121 RFS 

1 (5) The Eisenhower Exchange Fellowship is de2 veloping a new program to broaden its geographic 

3 base to emphasize the relationship of the United 

4 States with the Arab world. 

5 (6) Congress has previously recognized the im6 portance of the work of the Eisenhower Exchange 

7 Fellowship program when it granted the program a 

8 Federal Charter under section 3(a) of Public Law 

9 101–454. 

10 (7) The Eisenhower Exchange Fellowship is one 

11 of the best examples of public and private partner12 ships. 

13 (8) Additional resources are required to achieve 

14 the goals and objectives of the Eisenhower Exchange 

15 Fellowship program in the 21st century. 

16 SEC. 3. AUTHORIZATION OF ADDITIONAL APPROPRIATIONS 

17 FOR THE EISENHOWER EXCHANGE FELLOW18 SHIP PROGRAM TRUST FUND. 

19 Section 5 of the Eisenhower Exchange Fellowship 

20 Act of 1990 (Public Law 101–454; 20 U.S.C. 5204) is 

21 amended—

22 (1) by striking ‘‘To provide’’ and inserting ‘‘(a) 

23 INITIAL ENDOWMENT.––To provide’’; and 

24 (2) by adding at the end the following new sub25 section: 
4

HR 2121 RFS 

1 ‘‘(b) ENHANCED ENDOWMENT.—In addition to the 

2 amount initially appropriated pursuant to the authoriza3 tion of appropriation under subsection (a), there is author4 ized to be appropriated to the Eisenhower Exchange Fel5 lowship Program Trust Fund $12,500,000 for fiscal year 

6 2004.’’.

Passed the House of Representatives July 6, 2004. 

Attest: JEFF TRANDAHL, 

Clerk.
[Federal Register Volume 69, Number 220 (Tuesday, November 16, 2004)]
[Notices]
[Page 67146]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-25528]


-----------------------------------------------------------------------

FEDERAL RESERVE SYSTEM


Sunshine Act Meeting

AGENCY HOLDING THE MEETING: Board of Governors of the Federal Reserve 
System.

TIME AND DATE: 11:30 a.m., Monday, November 22, 2004.

PLACE: Marriner S. Eccles Federal Reserve Board Building, 20th and C 
Streets, N.W., Washington, D.C. 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:
    1. Personnel actions (appointments, promotions, assignments, 
reassignments, and salary actions) involving individual Federal Reserve 
System employees.
    2. Any items carried forward from a previously announced meeting.

FOR FURTHER INFORMATION CONTACT: Michelle A. Smith, Director, Office of 
Board Members; 202-452-2955.

SUPPLEMENTARY INFORMATION: You may call 202-452-3206 beginning at 
approximately 5 p.m. two business days before the meeting for a 
recorded announcement of bank and bank holding company applications 
scheduled for the meeting; or you may contact the Board's Web site at 
http://www.federalreserve.gov for an electronic announcement that not 
only lists applications, but also indicates procedural and other 
information about the meeting.

    Board of Governors of the Federal Reserve System, November 12, 
2004.
Robert deV. Frierson,
Deputy Secretary of the Board.
[FR Doc. 04-25528 Filed 11-12-04; 3:11 pm]
BILLING CODE 6210-01-S
# L_2023049EN.01005301.xml

| 16.2.2023 | EN | Official Journal of the European Union | L 49/53 |
| --- | --- | --- | --- |

16.2.2023

EN

Official Journal of the European Union

L 49/53

---

DECISION OF THE EEA JOINT COMMITTEE No 25/2020

of 7 February 2020

amending Annex XIII (Transport) to the EEA Agreement [2023/303]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

| (1) | Commission Regulation (EU) 2018/1042 of 23 July 2018 amending Regulation (EU) No 965/2012, as regards technical requirements and administrative procedures related to introducing support programmes, psychological assessment of flight crew, as well as systematic and random testing of psychoactive substances to ensure medical fitness of flight and cabin crew members, and as regards equipping newly manufactured turbine-powered aeroplanes with a maximum certified take-off mass of 5 700 kg or less and approved to carry six to nine passengers with a terrain awareness warning system (1) is to be incorporated into the EEA Agreement. |
| --- | --- |

(1)

Commission Regulation (EU) 2018/1042 of 23 July 2018 amending Regulation (EU) No 965/2012, as regards technical requirements and administrative procedures related to introducing support programmes, psychological assessment of flight crew, as well as systematic and random testing of psychoactive substances to ensure medical fitness of flight and cabin crew members, and as regards equipping newly manufactured turbine-powered aeroplanes with a maximum certified take-off mass of 5 700 kg or less and approved to carry six to nine passengers with a terrain awareness warning system (1) is to be incorporated into the EEA Agreement.

| (2) | Annex XIII to the EEA Agreement should therefore be amended accordingly, |
| --- | --- |

(2)

Annex XIII to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following indent is added in point 66nf (Commission Regulation (EU) No 965/2012) of Annex XIII to the EEA Agreement:

| ‘— | 32018 R 1042: Commission Regulation (EU) 2018/1042 of 23 July 2018 (OJ L 188, 25.7.2018, p. 3).’ |
| --- | --- |

‘—

32018 R 1042: Commission Regulation (EU) 2018/1042 of 23 July 2018 (OJ L 188, 25.7.2018, p. 3).’

Article 2

The text of Regulation (EU) 2018/1042 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 8 February 2020, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 7 February 2020.

For the EEA Joint Committee

The President

Clara GANSLANDT

---

(1)  
  OJ L 188, 25.7.2018, p. 3.

1

(*1)  Constitutional requirements indicated.

*1

---
### [§475. Renumbered §405]
#### J. Hampden Dougherty, Appellant, v. The City of New York, Respondent.

Judgment and order affirmed, with costs. Ho opinion. Present — Ingraham, P. J., McLaughlin, Laughlin, Clarke and Scott, JJ.
Exhibit 32.2



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Quarterly Report of Marco Community Bancorp, Inc. (the Company) on Form 10-QSB for the period ended June 30, 2005 as filed with the Securities and Exchange Commission (the
Report), I, Thomas M. Whelan, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.§ 1350, as added by § 906 of the Sarbanes-Oxley Act of 2002, that:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for
the period covered by the report.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |     |  |                                                                   
|-------------------- |  | --- |  | ------------------------------------------------------------------
|Date: August 9, 2005 |  | By: |  | /s/ Thomas M. Whelan                                              
|                     |  |     |  | Thomas M. Whelan, Senior Vice Presidentand Chief Financial Officer
Electronically Filed

Intermediate Court of Appeals

CAAP-11-0000568

06-FEB-2015

09:55 AM
NRC PUBLISHES FINAL POLICY STATEMENT ON PROTECTION OF

CESIUM CHLORIDE RADIATION SOURCES

The Nuclear Regulatory Commission has issued its final policy statement on the 

protection of sealed radiation sources containing cesium-137 chloride (CsCl). 

Cesium chloride sources are used in blood irradiation, bio-medical and industrial 

research, and calibration of instrumentation and dosimetry. They have received special attention 

because the cesium chloride powder is highly soluble and dispersible, which could present 

security concerns if not properly secured.

The statement, published today in the Federal Register, describes the Commission’s 

policy and expectations on the secure uses of cesium chloride sources and the agency’s potential 

actions should the threat environment change. The policy statement emphasizes that the security 

of radiation sources is an essential part of the NRC’s mission, cesium chloride sources are 

adequately protected under current NRC requirements, and the NRC encourages voluntary 

design improvements that could further enhance their security.

While noting the beneficial uses of cesium chloride sources, the policy statement 

encourages development of alternative forms of cesium-137. It also expresses the NRC’s view 

that it is “imperative to develop a pathway for the long-term storage and disposal of these 

sources whether or not alternative forms are developed.”

The policy statement discusses security improvements that have been imposed by the 

NRC and state agencies following the terrorist events of Sept. 11, 2001, as well as voluntary 

programs initiated by other government agencies to enhance security beyond NRC requirements. 

The NRC published a draft policy statement in the Federal Register on June 29, 2010, 

and held a public workshop to receive public comments Nov. 8-9. The final policy statement 

reflects the public comments received on the draft policy statement.

###

News releases are available through a free listserv subscription at the following Web address: 

http://www.nrc.gov/public-involve/listserver.html. The NRC homepage at www.nrc.gov also offers a SUBSCRIBE 

link. E-mail notifications are sent to subscribers when news releases are posted to NRC’s website.

NRC NEWS

U.S. NUCLEAR REGULATORY COMMISSION

Office of Public Affairs Telephone: 301/415-8200

Washington, D.C. 20555-0001

E-mail: opa.resource@nrc.gov Site: www.nrc.gov

Blog: http://public-blog.nrc-gateway.gov

No. 11-140 July 25, 2011
EMPLOYER DETERMINATION

Marquette & Huron Mountain Railroad Company

This is the determination of the Railroad Retirement Board regarding the continued

status of Marquette & Huron Mountain Railroad Company (MHM), B.A. No. 3627, as

a employer under the Railroad Retirement Act (45 U.S.C. §231 et seq.HRRA) and 

Railroad Unemployment Insurance Act (45 U.S.C. §351 et seq.HRUIA).

According to the Board's records, Mr. John A. Zerbel was president of MHM, Railroad

Recreation, Inc. (RRI) (B.A. No. 9616), Wisconsin Western Railroad Corporation

(WWRC) (B.A. No. 3642), and Southeastern Wisconsin Transportation Corporation

(SWTC) (B.A. 3634). See Legal Opinion L-84-88. RRI, WWRC, and SWTC ceased

operations and coverage of these companies under the Acts was terminated in 1 984.

The Board's records indicate that MHM has not submitted an annual report to the

Board since 1988. John A. Zerbel is no longer living.

The only available information suggests that MHM ceased operations prior to 1989

and that the company last compensated employees in 1 988. Accordingly, the Board

finds that effective with the close of business December 31, 1988, Marquette &

Huron Mountain Railroad Company ceased to be an employer under the RRA and the

RUIA.

Glen L. Bower

V. M/Speakman, Jr.

BCD 1995-114 BA # 3627
#### § 890.1034 Counting a period of suspension as part of a subsequent debarment.

The debarring official may consider the provider's contiguous period of suspension when determining the length of a debarment.
BISNIS Trades & Tenders, July 27, 1998 - PART 2

----
#### In the Matter of the Application of Frank R. Lyon, Jr., for Admission to Practice as an Attorney. (From the State of West Virginia.)

Present — Nolan, P. J., Carswell, Adel, Sneed and Wenzel, JJ.
#### § 13.2 Definitions.

*Department* means the U.S. Department of Commerce.

*Order* means Executive Order 12372, issued July 14, 1982, and amended April 8, 1983 and titled “Intergovernmental Review of Federal Programs.”

*Secretary* means the Secretary of the U.S. Department of Commerce or an official or employee of the Department acting for the Secretary under a delegation of authority.

*State* means any of the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Commonwealth of the Northern Mariana Islands, Guam, American Samoa, the U.S. Virgin Islands, or the Trust Territory of the Pacific Islands.
<PAGE>


                                                                   Exhibit 10.54


                                     WAIVER

         This Waiver is made into as of November 8, 2004 (the "Waiver"), by and
between COMERICA BANK ("Bank"), and GENAISSANCE PHARMACEUTICALS, INC.
("Borrower").

                                    RECITALS

         Borrower and Bank are parties to that certain Loan and Security
Agreement dated as of September 30, 2003, as amended by a First Amendment to
Loan and Security Agreement dated as of March 16, 2004 (collectively, the
"Agreement"). At the request of Borrower, Bank desires to waive compliance by
Borrower of two provisions of the Agreement, to the extent set forth in this
Waiver.

         NOW, THEREFORE, the parties agree as follows:

         1. Bank waives compliance by Borrower of (i) Section 6.9 of the
Agreement for the period from August 31, 2004 through October 5, 2004 and (ii)
Section 6.8 for the period from the date hereof through November 30, 2004. By
December 23, 2004, Borrower shall report compliance with Section 6.8. This is
not a continuing waiver, and Borrower shall comply with such Sections for all
other periods, and all other provisions of the Agreement.

         2. As a condition to the effectiveness of this Waiver, Borrower shall
pay Bank a fee of $5,000 plus Bank Expenses incurred in connection herewith up
to $1,500. Unless otherwise defined, all initially capitalized terms in this
Waiver shall be as defined in the Agreement. The Agreement, as amended hereby,
shall be and remain in full force and effect in accordance with its respective
terms and hereby is ratified and confirmed in all respects. Except as expressly
set forth herein, the execution, delivery, and performance of this Waiver shall
not operate as a waiver of, or as an amendment of, any right, power, or remedy
of Bank under the Agreement, as in effect prior to the date hereof.

         3. Borrower represents and warrants that the representations and
warranties contained in the Agreement are true and correct as of the date of
this Waiver, and that no Event of Default has occurred and is continuing. This
Waiver may be executed in two or more counterparts, each of which shall be
deemed an original, but all of which together shall constitute one instrument.

         IN WITNESS WHEREOF, the undersigned have executed this Waiver as of the
first date above written.

                                           GENAISSANCE PHARMACEUTICALS, INC.

                                           By: /s/ Ben D. Kaplan
                                               -----------------------------

                                           Title:  Senior VP & CFO



                                           COMERICA BANK

                                           By: /s/ Ron W. Homa
                                               -----------------------------

                                           Title:  Vice President